The Protein Brewery raised $20.5M as a Series B extension, despite an FDA GRAS setback for its US plans.
- Amount
- $20.5M
- Stage
- Series B
- Announced
- 29 June 2026
- Lead
- ABN AMRO Sustainable Impact Fund
- Other investors
- Invest-NL, Novo Holdings, Madeli, Brabant Development Agency (BOM)
- Use of funds
- Expand Dutch production capacity to 2,000+ tons, drive European sales, fund clinical studies and regulatory applications
- Checked
- Amount and date checked against the press source